Report

Rat Model Market By Type (Outbred Rats, Inbred Rats, Genetically Modified Rats, Hybrid/Congenic Rats, Conditioned/Surgically Modified Rats, Immunodeficient Rats); By Technology (Nuclear Transfer, Embryonic Stem Cell, Microinjection, Others); By Service (Cryopreservation, Breeding, Rederivation, Genetic testing, Quarantine Depending, Other); By Application (Oncology, Neurology, Immunology, Toxicology, Others); By End-Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs) Global Opportunity Analysis and Industry Forecast To 2030

  • Publish Date: Jul,2022
  • Report ID: QI038
  • Page : 200
  • Report Type : PDF (Email)
The global rat model market size was US$ 636 million in 2021. The global rat model market size is forecast to reach US$ 1,327 million by 2030, growing at a compound annual growth rate (CAGR) of 8.6% during the forecast period from 2022 to 2030.

A rat model is a non-human, living, genetically modified animal utilized in scientific study and the exploration of human diseases. These rat models have also been utilized to gain a better knowledge of the human disease process without causing harm to humans. Because their pathophysiology is similar to disease situations that are similar in humans, rat models resemble human disease. The recurrence and course of rat diseases are identical to those of humans under certain situations. Because rats and humans have so many anatomical and physiological similarities, researchers have used these study models to investigate a wide range of causes and test new therapeutics.

Factors Influencing Market Growth
The increasing development of new medical devices and biotechnological products drives the global market.
The growing production of monoclonal antibodies and the rising demand for personalized humanized rat models due to the increasing consumption of personalized medicines is forecast to offer lucrative opportunities for the global market.
Stringent regulations and policies may slow down the overall market growth.

Impact Analysis of COVID-19
The COVID-19 pandemic had a positive impact on the global market. Despite the pandemic, heavy investments in COVID-19 research and increased financing for R&D initiatives to develop novel treatments have encouraged the use of rat testing. Several pharmaceutical businesses, biotechnology corporations, and clinical research organizations changed their clinical trial R&D spending in contrast to the previous spending, reflecting the pandemic's extent of disruption. As a result, clinical research and development operations were continued, ensuring the inflow and use of rat models. Therefore, aiding the expansion of the rat model market.

Regional Analysis
North America accounted for a major market share in 2021 and is forecast to have substantial growth during the forecast period. As a result of the rising research activities, increasing demand for personalized medication, and a surge in healthcare expenditure.

The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the rising number of academic and contract research organizations in leading countries like Japan, China, Australia, and India.

Leading Competitors
The leading prominent companies profiled in the global rat model market are:
GenOway
Charles River Laboratories International, Incorporated
Envigo
Covance Incorporated
Horizon Discovery Group plc
Janvier Labs
Taconic Biosciences, Incorporated
Biomedical Research Models (Biomere)
Other Prominent Players

Scope of the Report
The global rat model market segmentation focuses on Type, Technology, Service, Application, End-Use, and Region.
Segmentation based on Type
Outbred Rats
Inbred Rats
Genetically Modified Rats
Hybrid/Congenic Rats
Conditioned/Surgically Modified Rats
Immunodeficient Rats
Segmentation based on Technology
Nuclear Transfer
Embryonic Stem Cell
Microinjection
Others
Segmentation based on Service
Cryopreservation
Breeding
Rederivation
Genetic testing
Quarantine Depending
Other
Segmentation based on Application
Oncology
Neurology
Immunology
Toxicology
Others
Segmentation based on End-Use
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations (CROs)
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America

Meta Title: Rat Model Market Size, Share, Insight and Forecast 2022 To 2030
Meta Description: Global Rat Model Market is projected to reach US$ 1,327 million by the end of 2030 from US$ 636 million in 2021, at a CAGR of 8.6%
Meta Keywords: rat model market Size, rat model market share, rat model market trend, rat model market Forecast, rat model market insight